Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.
Publication
, Journal Article
Sachais, BS; Paradiso, S; Strauss, D; Shaz, BH
Published in: Blood Adv
June 27, 2017
Duke Scholars
Published In
Blood Adv
DOI
ISSN
2473-9529
Publication Date
June 27, 2017
Volume
1
Issue
15
Start / End Page
1142 / 1147
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sachais, B. S., Paradiso, S., Strauss, D., & Shaz, B. H. (2017). Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions. Blood Adv, 1(15), 1142–1147. https://doi.org/10.1182/bloodadvances.2017008334
Sachais, Bruce S., Sarai Paradiso, Donna Strauss, and Beth H. Shaz. “Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.” Blood Adv 1, no. 15 (June 27, 2017): 1142–47. https://doi.org/10.1182/bloodadvances.2017008334.
Sachais BS, Paradiso S, Strauss D, Shaz BH. Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions. Blood Adv. 2017 Jun 27;1(15):1142–7.
Sachais, Bruce S., et al. “Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.” Blood Adv, vol. 1, no. 15, June 2017, pp. 1142–47. Pubmed, doi:10.1182/bloodadvances.2017008334.
Sachais BS, Paradiso S, Strauss D, Shaz BH. Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions. Blood Adv. 2017 Jun 27;1(15):1142–1147.
Published In
Blood Adv
DOI
ISSN
2473-9529
Publication Date
June 27, 2017
Volume
1
Issue
15
Start / End Page
1142 / 1147
Location
United States
Related Subject Headings
- 3201 Cardiovascular medicine and haematology